|
Miltenyi Biotec
anti hu-lif apc; rea350 Anti Hu Lif Apc; Rea350, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti-human+lif+antibody/LIF+Antibody%2C+anti-human%2C+REAfinity/pmc06859474-76-0-6 Average 94 stars, based on 1 article reviews
anti hu-lif apc; rea350 - by Bioz Stars,
2026-09
94/100 stars
|
Buy from Supplier |
|
Northern Biologics
humanized anti-lif antibody msc-1 Humanized Anti Lif Antibody Msc 1, supplied by Northern Biologics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti-human+lif+antibody/humanized+anti+lif+antibody+msc+1/pmc08556368-192-12-6 Average 90 stars, based on 1 article reviews
humanized anti-lif antibody msc-1 - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Becton Dickinson
pe-conjugated anti-human lif receptor (lifr) antibody ![]() Pe Conjugated Anti Human Lif Receptor (Lifr) Antibody, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti-human+lif+antibody/pe+conjugated+anti+human+lif+receptor++lifr++antibody/pmc09100112-57-27-32 Average 90 stars, based on 1 article reviews
pe-conjugated anti-human lif receptor (lifr) antibody - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
AstraZeneca ltd
humanized anti-lif antibody msc-1 ![]() Humanized Anti Lif Antibody Msc 1, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti-human+lif+antibody/humanized+anti+lif+antibody+msc+1/pmc11340043-168-2-6 Average 90 stars, based on 1 article reviews
humanized anti-lif antibody msc-1 - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Bio-Techne corporation
human lif antibody ![]() Human Lif Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti-human+lif+antibody/Human+LIF+Antibody/bio-techne+corporation___mab250 Average 93 stars, based on 1 article reviews
human lif antibody - by Bioz Stars,
2026-09
93/100 stars
|
Buy from Supplier |
|
Recombinant Mouse Antibody scFv Fragment is capable of binding to Human LIF, expressed in E. coli.Antibody assay: Enzyme-linked Immunosorbent Assay; Immunoprecipitation; Functional Study≤6 months at 4°C; ≥6 months at -20°C.http://www.creativebiolabs.net/Rcombinant-Anti-Human-LIF-Antibody-scFv-Fragment-6212.htm
|
Buy from Supplier |
|
Recombinant Mouse Antibody is capable of specifically reacting with Human LIF, expressed in Chinese Hamster Ovary cells(CHO).Antibody assay: Enzyme-linked Immunosorbent Assay; Western blot; Immunoprecipitation; Functional Study4°C. For long term storage, aliquot and store at -20°C.
|
Buy from Supplier |
|
Recombinant Mouse Antibody Fab Fragment prepared by a genetic engineering technique which specifically reacts with Human LIF, expressed in Chinese Hamster Ovary cells(CHO).Antibody assay: Western blot; Immunofluorescence; Functional StudyStore at -20°C. Open under aseptic conditions.http://www.creativebiolabs.net/Rcombinant-Anti-Human-LIF-Antibody-Fab-Fragment-6211.htm
|
Buy from Supplier |
|
Rabbit anti-Human LIF Polyclonal Antibody
|
Buy from Supplier |
Image Search Results
Journal: Cancers
Article Title: Gp130-Mediated STAT3 Activation Contributes to the Aggressiveness of Pancreatic Cancer through H19 Long Non-Coding RNA Expression
doi: 10.3390/cancers14092055
Figure Lengend Snippet: Active gp130/STAT3 pathway in PANC-1 sphere cells. ( A ) Real-time qPCR analysis of IL-6 , LIF , IL-6R , LIFR , and gp130 in PANC-1 cells cultured in 2D (adherent) or 3D (sphere) conditions. The results presented are normalized to values obtained for adherent cells (value = 1). Results are presented as means ± SD from three independent experiments. ( B ) FACS analysis of IL-6R, LIFR, and gp130 expression in PANC-1 cells cultured in 2D (adherent) or 3D (sphere) conditions. Controls are indicated by thin lines with gray color. ( C ) Cell surface levels of IL-6R, LIFR, and gp130 expression in PANC-1 cells cultured in 2D (adherent) or 3D (sphere) conditions. Mean fluorescence intensities (MFIs) relative to those of adherent cells are presented. Results are presented as means ± SD from three independent experiments. ( D ) Western blot analysis of p-gp130, gp130, p-STAT3, and STAT3 was performed in PANC-1 cells cultured in 2D (adherent) or 3D (sphere) conditions. Relative band intensity is provided. ** p < 0.01.
Article Snippet: Cells were harvested, and dissociated single cells were incubated on ice for 30 min with PE-conjugated anti-human IL-6 receptor α (IL-6Rα) antibody (BioLegend, San Diego, CA), PE-conjugated
Techniques: Cell Culture, Expressing, Fluorescence, Western Blot
Journal: Cancers
Article Title: Gp130-Mediated STAT3 Activation Contributes to the Aggressiveness of Pancreatic Cancer through H19 Long Non-Coding RNA Expression
doi: 10.3390/cancers14092055
Figure Lengend Snippet: The correlation of gp130/STAT3 pathway-related factor expression with overall survival and H19 expression correlated with gp130/STAT3 pathway-related factors in patients with PDAC. Each survival curve was presented according to the online database GEPIA. ( A ) IL-6 , ( B ) LIF , ( C ) IL-6R , ( D ) LIFR , ( E ) gp130 (IL-6ST) , ( F ) JAK1 , ( G ) STAT3 , ( H ) TGF β-RII (TGFBR2) , ( I ) MT1-MMP (MMP14) , and ( J ) H19 . ( K ) The correlation of H19 and gp130/STAT3 pathway-related factor expression in patients with PDAC was assessed using Spearman rank correlation analysis according to the online database GEPIA.
Article Snippet: Cells were harvested, and dissociated single cells were incubated on ice for 30 min with PE-conjugated anti-human IL-6 receptor α (IL-6Rα) antibody (BioLegend, San Diego, CA), PE-conjugated
Techniques: Expressing
Journal: Cancers
Article Title: Gp130-Mediated STAT3 Activation Contributes to the Aggressiveness of Pancreatic Cancer through H19 Long Non-Coding RNA Expression
doi: 10.3390/cancers14092055
Figure Lengend Snippet: Schematic representation of autocrine/paracrine IL-6 or the LIF/gp130/STAT3 pathway in PDAC sphere cells. In PDAC sphere cells in which CSCs are enriched (CSC-like cells), binding of autocrine/paracrine IL-6 or LIF to each receptor (IL-6R or LIFR, respectively) induces gp130 homodimerization or LIFR/gp130 complex formation to thereby activating JAKs followed by phosphorylation of gp130, ultimately leading to STAT3 activation. This pathway contributes to the maintenance of stemness features and expression of MT1-MMP and TGFβ-RII. Expression of TGFβ-RII via the gp130/STAT3 pathway affects TGF-β1/Smad signaling to promote EMT induction. Additionally, p-STAT3 can access the active promoter region of H19 and contribute to its transcription. Therefore, autocrine/paracrine IL-6 or the LIF/gp130/STAT3 pathway in PDAC CSC-like cells is believed to eventually lead to invasion and metastasis, both of which are hallmarks of malignancy.
Article Snippet: Cells were harvested, and dissociated single cells were incubated on ice for 30 min with PE-conjugated anti-human IL-6 receptor α (IL-6Rα) antibody (BioLegend, San Diego, CA), PE-conjugated
Techniques: Binding Assay, Phospho-proteomics, Activation Assay, Expressing